Browsing Category
Dr. Paul Lohmann
Gastroretentive systems for prolonged release of metformin based on osmotically driven expansion
Abstract
Metformin is a relatively old drug mainly used to treat type 2 and gestational diabetes, which needs to be administered two or three times a day in high doses. It has a high aqueous solubility and is poorly absorbed following oral intake. Aiming to achieve a gastroretentive formulation for…
Read More...
Read More...
pH-responsive agarose hydrogel for enhanced gastrointestinal ibuprofen delivery: A novel…
Abstract
Recent advances in pH-responsive drug delivery systems have demonstrated their promising potential for targeted therapeutic delivery. However, challenges remain in developing platforms that combine precise spatiotemporal control with robust mechanical properties. Herein, we present a novel…
Read More...
Read More...
Lipid-Based Formulation of Nateglinide as a Promising Strategy for Managing Solubility Challenges in…
Abstract
The present study focuses on the development and optimization of a solid self-microemulsifying drug delivery system (SSMEDDS) of Nateglinide, a poorly water-soluble antidiabetic drug, to enhance its oral bioavailability. Initially, a liquid
SMEDDS was formulated using Capmul MCM as the…
Read More...
Read More...
Preparation and Characterization of Diclofenac Sodium-Purolite A430MR Complexes for Taste Masking
Abstract
The taste of a drug impacts the compliance of patients for oral administration. In this study, the bitter taste of diclofenac sodium (DS) was masked with purolite A430MR through ion exchange. The DS-A430MR complexes (DACs) were prepared at a 1:1 (w/w) drug to resin through a simple aqueous…
Read More...
Read More...
Assessment of leachables and extractables in “super-swelling” hydrogel-forming microarray patches
Abstract
Hydrogel-forming microarray patches (MAPs) offer a minimally invasive platform for transdermal drug delivery, enabling systemic absorption of active pharmaceutical ingredients. Unlike dissolving MAPs, which deposit their entire polymer matrix into the skin, hydrogel-forming MAPs remain…
Read More...
Read More...
Twenty grams in two weeks: Material sparing tablet development of direct compression formulations…
Abstract
Material-sparing tablet development (MSTD) describes an approach to tablet formulation development that uses the active pharmaceutical ingredient's (API) material properties to guide formulation design. The work presented here expands on this methodology and demonstrates its application…
Read More...
Read More...
Hydroxypropyl-β-Cyclodextrin-Enhanced Azelaic Acid Hydrogel for Acne Treatment: Evaluation of…
Abstract
Purpose
Azelaic acid (AZE) is a widely used agent in acne treatment, but its poor water solubility limits its therapeutic potential. In this study, the effectiveness of azelaic acid (AZE)—a compound with limited therapeutic efficacy due to its poor water solubility—was investigated in…
Read More...
Read More...
Feasibility of Hot Melt Extrusion in Converting Water-Based Nanosuspensions into Solid Dosage Forms
Abstract
Aim: In addition to numerous benefits provided by nanosuspensions (NSs) (e.g., enhanced saturation solubility, increased area for interaction with fluids), they suffer from major stability, handling and compliance issues. To overcome these challenges, we evaluated the feasibility of hot…
Read More...
Read More...
Impact of antioxidant addition on drug dissolution: Implications for NDSRI mitigation biowaivers
Abstract
Nitrosamine impurities have garnered recent attention due to their presence in pharmaceuticals and their mutagenic risks. Recent studies have emphasized controlling impurities and suggest ways to mitigate the further formation of nitrosamines by the addition of antioxidants to tablets and…
Read More...
Read More...
Development and Evaluation of Sublingual Tablet of Lercanidipine by Solid Dispersion Method
Abstract
The purpose of this study was to develop and evaluate a sublingual tablet of lercanidipine hydrochloride for the direct compression method of treating hypertension by using a solid dispersion technique. The dihydropyridine calcium-channel blocker lercanidipine Hydrochloride is used to…
Read More...
Read More...